Zynex inc.

About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com. Forward-Looking …Oct 31, 2023 · Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ... Find the latest Zynex, Inc. (ZYXI) stock quote, history, news and other vital information to help you with your stock trading and investing.WebUnder the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC ...

We’ve been at it for more than 25 years, and we’re just getting started. Zynex, Inc. was founded by Thomas Sandgaard in 1996 to develop advanced electrotherapy technology that alleviates chronic pain and aids the recovery of patients affected by debilitating illnesses. Every investor in Zynex, Inc. (NASDAQ:ZYXI) should be aware of the most powerful shareholder groups. We can see that individual insiders own the lion's share in the company with 45% ownership.

Dan Moorhead is the Chief Financial Officer and responsible for all finance and accounting functions. Prior to joining Zynex, Mr. Moorhead was Chief Financial Officer of Evolving Systems, Inc. (Nasdaq: EVOL) from January 2016 until June 2017, after having served as Vice President of Finance & Administration from December 2011 through December 2015 …Zynex Pro TLSO; OA Knee Brace; Zynex Pro Wrist Brace; Post-Op Knee Brace; Saunders Cervical Traction; ComforTrac Cervical Traction; Zynex CryoHeat; E …Web

ENGLEWOOD, Colo., March 6, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will postpone the release of its fourth quarter and full year financial results and conference call initially ...Q3 2023 Revenue Increased 20% to $49.9 Million; EPS $0.10. ENGLEWOOD, Colo., Oct. 26, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has reported its financial and operational results for the third quarter ended ...Zynex, Inc. had approximately 41.9 million shares issued and 33.9 million shares outstanding as of October 30, 2023. About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring ...Nov 15, 2023 · Zynex. 15 Nov, 2023, 09:15 ET. ENGLEWOOD, Colo., Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non ... Zynex. 15 Nov, 2023, 09:15 ET. ENGLEWOOD, Colo., Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non ...

BLFS. BioLife Solutions Inc. 13.57. UNCH. UNCH. Get Zynex Inc (ZYXI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...

Zynex, Inc. announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical …WebAbout us. Zynex, Inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. Zynex ...WebZynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year Zynex, Inc. (NASDAQ: ZYXI), an innovative medical …WebMay 4, 2023 · Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced that Thomas Sandgaard, its Chief Executive Officer (the "Selling Stockholder"), has determined not to pursue the public offering of 2,000,000 ... Zynex Inc. Thomas Sandgaard is the Founder, Chairman, President & CEO of Zynex, Inc., a publicly-traded medical device company founded in 1996. The team at Zynex is committed to being the world’s leading pain management provider. They are traded under NASDAQ ZYXI. Zynex’s mission is to improve the quality of life of patients suffering from ...

Zynex Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $44.95 million for the quarter ended June 2023, surpassing the Zacks Consensus Estimate by 1.02%. This ...Zynex has 5 employees at their 1 location and $158.17 m in annual revenue in FY 2022. See insights on Zynex including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.Zynex, Inc. ZYXI: Rating increased to a HOLD ZYNEX INC has an Investment Rating of HOLD; a target price of $6.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety ... Zynex, Inc., a leading medical technology company specializing in the production and sale of innovative non-invasive medical devices for pain relief, rehabilitation, and patient monitoring, has made an exciting announcement. On November 1, 2023, the company’s board of directors gave their approval for a stock repurchase program, …zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. …Orders increased 48%; highest number of orders in Company history for the 3 rd consecutive quarter. Revenue increased 21% year over year to $48.8 million. Net income of $7.5 million; Diluted EPS …WebZynex, Inc. has a 52-week low of $6.88 and a 52-week high of $17.25. The company has a market cap of $314.97 million, a price-to-earnings ratio of 21.60 and a beta of 0.61.

Mar 13, 2023 · Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 5.26% and 1.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zynex, Inc. Common Stock (ZYXI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.WebZynex, Inc. (NASDAQ: ZYXI), is an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for painZynex, Inc. (NASDAQ:NASDAQ:ZYXI) Q3 2023 Earnings Conference Call October 26, 2023 4:15 PM ETCompany ParticipantsQuinn Callanan - Investor RelationsThomas...Zynex, Inc., a leading medical technology company specializing in the production and sale of innovative non-invasive medical devices for pain relief, rehabilitation, and patient monitoring, has made an exciting announcement. On November 1, 2023, the company’s board of directors gave their approval for a stock repurchase program, …Financial Information. This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. Please note: All data in this section is provided by a 3rd party provider and may be delayed up to ...Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Corporate Governance Zynex, Inc.’s ISS Governance QualityScore as of November 1, 2023 is 7.

About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser ...

Zynex Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $42.17 million for the quarter ended March 2023, surpassing the Zacks Consensus Estimate by 6.30%. This ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...Nov 1, 2023 · Zynex, Inc. had approximately 41.9 million shares issued and 33.9 million shares outstanding as of October 30, 2023. About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and ... Aug 9, 2023 · Zynex. 09 Aug, 2023, 09:15 ET. ENGLEWOOD, Colo., Aug. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non ... Zynex, Inc. announced that China's State Food and Drug Administration has granted clearance to market its NeuroMove(TM) stroke recovery device. The NeuroMove(TM) device increases the functionality of many stroke victims by teaching the healthy parts of the brain to compensate for damaged areas.When it comes to staying informed and up-to-date with the latest news, there are countless options available. One popular choice for many people is Apple News, a news aggregator developed by Apple Inc.The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.Zynex Inc, an innovative medical technology company, said on Wednesday that its board of directors had approved a program to buy back up to $20.0 million of its own common stock. The program is to begin on November 1st and is slated to end on the earlier of November 1st 2024, or when the $20.0 million limit is reached.Zynex Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive. Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today. Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate.Zynex, Inc. develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. The Company's devices are intended for pain management and provide rehabilitation and through the utilization of …ENGLEWOOD, Colo., Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked within Forbes' …Zynex Inc. ZYXI came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.13 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced earnings …

Zynex, Inc. Common Stock (ZYXI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.WebZynex, Inc. had approximately 41.7 million shares issued and 35.1 million shares outstanding as of September 8, 2023. About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and ...Nov 24, 2023 · Zynex, Inc. (NASDAQ:ZYXI) posted its quarterly earnings data on Thursday, October, 26th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. The firm had revenue of $49.92 million for the quarter, compared to analyst estimates of $49.50 million. Instagram:https://instagram. gabi homeowners insurancezim stock dividend 2023docu stock forecastjeters Mar 13, 2023 · Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 5.26% and 1.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? Track Zynex Inc (ZYXI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors best free stock analysis appare sports cards a good investment Zynex, Inc. Company Profile | Englewood, CO | Competitors, Financials & Contacts - Dun & Bradstreet.About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser ... is svol a good investment Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than ...zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. …Nov 15, 2023 · Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...